Piscataqua Savings Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22
Closed -$4.34K 415
2026
Q1
$4.34K Sell
22
-1
-4% -$193 ﹤0.01% 372
2025
Q4
$4.14K Buy
+23
New +$4.03K ﹤0.01% 366
2025
Q3
Sell
-26
Closed -$3.63K 352
2025
Q2
$3.63K Buy
+26
New +$3.64K ﹤0.01% 332
2024
Q3
Sell
-18
Closed -$2.73K 346
2024
Q2
$2.73K Sell
18
-15
-45% -$2.26K ﹤0.01% 318
2024
Q1
$4.4K Buy
33
+15
+83% +$1.99K ﹤0.01% 311
2023
Q4
$2.36K Hold
18
﹤0.01% 322
2023
Q3
$2.37K Hold
18
﹤0.01% 327
2023
Q2
$2.5K Hold
18
﹤0.01% 322
2023
Q1
$2.43K Sell
18
-17
-49% -$2.29K ﹤0.01% 321
2022
Q4
$4.75K Hold
35
﹤0.01% 287
2022
Q3
$4K Hold
35
﹤0.01% 291
2022
Q2
$5K Hold
35
﹤0.01% 280
2022
Q1
$5K Hold
35
﹤0.01% 296
2021
Q4
$4K Hold
35
﹤0.01% 305
2021
Q3
$4K Buy
+35
New +$4.07K ﹤0.01% 304

Other funds holding AZN

Piscataqua Savings Bank's AZN Position: Q2 2026 in Review

Piscataqua Savings Bank sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 22 shares — an estimated $4.34K sold.

Piscataqua Savings Bank first reported a position in AZN in Q3 2021 and held it in 15 quarters. The position peaked at $5K in Q2 2022. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Piscataqua Savings Bank reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Piscataqua Savings Bank sold 22 AstraZeneca shares in Q2 2026, an estimated $4.34K.
  • Piscataqua Savings Bank first reported a position in AstraZeneca in Q3 2021 and held it in 15 quarters.
  • Piscataqua Savings Bank's AstraZeneca position peaked at $5K in Q2 2022.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.